Tobacco smoking and excess mortality in multiple sclerosis: A cohort study

Journal of Neurology, Neurosurgery and Psychiatry

Volumn 85, Issue 10, 2014, Pages 1091-1095

  Manouchehrinia, Ali ^a   Weston, Mikail ^a   Tench, Christopher R ^a   Britton, John ^a   Constantinescu, Cris S ^a  

^a UNIVERSITY OF NOTTINGHAM   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CAUSE OF DEATH; COHORT ANALYSIS; CONTROLLED STUDY; DISABILITY; DISEASE SEVERITY; FEMALE; FOLLOW UP; HUMAN; LIFESPAN; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MORTALITY; MORTALITY RATE; MORTALITY RISK; MULTIPLE SCLEROSIS; PREVALENCE; PRIORITY JOURNAL; SMOKING; STANDARDIZED MORTALITY RATIO; SURVIVAL RATE; PREMATURE MORTALITY; PROPORTIONAL HAZARDS MODEL; UNITED KINGDOM;

MULTIPLE SCLEROSIS;

CAUSE OF DEATH; COHORT STUDIES; DISABILITY EVALUATION; FEMALE; GREAT BRITAIN; HUMANS; MALE; MIDDLE AGED; MORTALITY, PREMATURE; MULTIPLE SCLEROSIS; PROPORTIONAL HAZARDS MODELS; SMOKING; SURVIVAL RATE;

EID: 84908348860     PISSN: 00223050     EISSN: 1468330X     Source Type: Journal    
DOI: 10.1136/jnnp-2013-307187     Document Type: Article

References (35)

1. Bronnum-Hansen H, Koch-Henriksen N, Stenager E. Trends in survival and cause of death in Danish patients with multiple sclerosis. Brain 2004; 127(Pt 4):844-50.
2. Sadovnick AD, Ebers GC, Wilson RW, et al. Life expectancy in patients attending multiple sclerosis clinics. Neurology 1992; 42:991-4.
3. Kingwell E, van der Kop M, Zhao Y, et al. Relative mortality and survival in multipl sclerosis: findings from British Columbia, Canada. J Neurol Neurosurg Psychiatry 2012; 83:61-6.
4. Scalfari A, Knappertz V, Cutter G, et al. Mortality in patients with multiple sclerosis Neurology 2013; 81:184-92.
5. WHO. WHO report on the global tobacco epidemic: warning about the dangers of tobacco. 2011.
6. Sakata R, McGale P, Grant EJ, et al. Impact of smoking on mortality and life expectancy in Japanese smokers: a prospective cohort study. BMJ 2012; 345:e7093
7. Huxley RR, Woodward M. Full hazards of smoking and benefits of stopping for women. Lancet 2013; 381:96-8.
8. Hernan MA, Jick SS, Logroscino G, et al. Cigarette smoking and the progression of multiple sclerosis. Brain 2005; 128(Pt 6):1461-5.
9. Sundstrom P, Nystrom L. Smoking worsens the prognosis in multiple sclerosis. Mult Scler 2008; 14:1031-5.
10. Healy BC, Ali EN, Guttmann CR, et al. Smoking and disease progression in multiple sclerosis. Arch Neurol 2009; 66:858-64.
11. Manouchehrinia A, Tench CR, Maxted J, et al. Tobacco smoking and disability progression in multiple sclerosis: United Kingdom cohort study. Brain 2013; 136(Pt 7):2298-304.
12. Elbaz A, Bower JH, Peterson BJ, et al. Survival study of Parkinson disease in Olmsted County, Minnesota. Arch Neurol 2003; 60:91-6.
13. Nortvedt MW, Riise T, Maeland JG. Multiple sclerosis and lifestyle factors: the Hordaland Health Study. Neurol Sci 2005; 26:334-9.
14. Poser CM, Paty DW, Scheinberg L, et al. New diagnostic criteria for multiple sclerosis: guidelines for research protocols. Ann Neurol 1983; 13:227-31.
15. McDonald WI, Compston A, Edan G, et al. Recommended diagnostic criteria for multiple sclerosis: guidelines from the International Panel on the diagnosis of multiple sclerosis. Ann Neurol 2001; 50:121-7.
16. Kurtzke JF Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology 1983; 33:1444-52.
17. Roxburgh RH, Seaman SR, Masterman T, et al. Multiple Sclerosis Severity Score: using disability and disease duration to rate disease severity. Neurology 2005; 64:1144-51.
18. Hirst C, Swingler R, Compston DA, et al. Survival and cause of death in multiple sclerosis: a prospective population-based study. J Neurol Neurosurg Psychiatry 2008; 79:1016-21.
19. Doll R, Peto R, Boreham J, et al. Mortality in relation to smoking: 50 years' observations on male British doctors. BMJ 2004; 328:1519.
20. Office for National Statistics. 2012. http://www.statistics.gov.uk/hub/population/deaths/mortality-rates.
21. StataCorp. Stata Statistical Software: Release 11. College Station, TX: StataCorp LP, 2009.
22. Peto R, Darby S, Deo H, et al. Smoking, smoking cessation, and lung cancer in the UK since 1950: combination of national statistics with two case-control studies. BMJ 2000; 321:323-9.
23. Mackenzie IS, Morant SV, Bloomfield GA, et al. Incidence and prevalence of multiple sclerosis in the UK 1990-2010: a descriptive study in the General Practice Research Database. J Neurol Neurosurg Psychiatry 2014; 85:76-84.
24. Sumelahti ML, Tienari PJ, Wikstrom J, et al. Survival of multiple sclerosis in Finland between 1964 and 1993. Mult Scler 2002; 8:350-5.
25. Smestad C, Sandvik L, Celius EG. Excess mortality and cause of death in a cohort of Norwegian multiple sclerosis patients. Mult Scler 2009; 15:1263-70.
26. Leray E, Morrissey SP, Yaouanq J, et al. Long-term survival of patients with multiple sclerosis in West France. Mult Scler 2007; 13:865-74.
27. Goodin DS, Reder AT, Ebers GC, et al. Survival in MS: a randomized cohort study 21 years after the start of the pivotal IFNbeta-1b trial. Neurology 2012; 78:1315-22.
28. Tsai CP, Lee CT. Impact of disease-modifying therapies on the survival of patients with multiple sclerosis in Taiwan, 1997-2008. Clin Drug Investig 2013; 33:647-52.
29. Rothman KJ, Greenland S, Lash TL. Modern epidemiology. 3rd edn. Philadelphia, PA: London: Lippincott Williams & Wilkins, 2008.
30. Lalmohamed A, Bazelier MT, Van Staa TP, et al. Causes of death in patients with multiple sclerosis and matched referent subjects: a population-based cohort study. Eur J Neurol 2012; 19:1007-14.
31. Becklake MR, Lalloo U. The 'healthy smoker': a phenomenon of health selection? Respiration 1990; 57:137-44.
32. Pope CA III, Burnett RT, Turner MC, et al. Lung cancer and cardiovascular disease mortality associated with ambient air pollution and cigarette smoke: shape of the exposure-response relationships. Environ Health Perspect 2011; 119:1616-21.
33. Marrie RA, Rudick R, Horwitz R, et al. Vascular comorbidity is associated with more rapid disability progression in multiple sclerosis. Neurology 2010; 74:1041-7.
34. Lange P, Vestbo J, Nyboe J. Risk factors for death and hospitalization from pneumonia. A prospective study of a general population. Eur RespirJ 1995; 8:1694-8.
35. LaCroix AZ, Lipson S, Miles TP, et al. Prospective study of pneumonia hospitalizations and mortality of U.S. older people: the role of chronic conditions, health behaviors, and nutritional status. Public Health Rep 1989; 104:350-60.